HLX43 dose 3: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
5
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 1 1
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Colorectal Cancer (CRC) | 1 |
| Colorectal cancer | 1 |
| Lung cancer | 1 |
| Non Small Cell Lung Cancer | 1 |
| Solid Tumor Cancer | 1 |
Recruiting trials involving HLX43 dose 3
- A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors
- Phase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of HLX43 (an Anti-PD-L1 ADC) in Subjects With Advanced Colorectal Cancer
Common questions
How many recruiting trials involve HLX43 dose 3?
2 recruiting trials across 5 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.